JOint Use of Database to Identify Risk Factors of CARDio-vascular Toxicity Induced by Immune Checkpoint Inhibitors (JOCARDITE)
JOint Use of Database to Identify Risk Factors of CARDio-vascular Adverse Reactions Induced by Immune Checkpoint InhibiTors: VigiBase, Entrepot de Données de Santé (EDS), Système National Des Données de Santé (SNDS) Databases and a Retrospective International Multicenter Registry of ICI-associated Myocarditis
Sponsor: Groupe Hospitalier Pitie-Salpetriere
A observational or N/A phase clinical study on Cardiomyopathies and Cardiovascular Diseases, this trial is ongoing. The trial is conducted by Groupe Hospitalier Pitie-Salpetriere and has accumulated 8 data snapshots since 2019. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
8 versions recorded-
Nov 2025 — Present [monthly]
Unknown
Status: Recruiting → Unknown
-
Sep 2024 — Nov 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Oct 2023 — Jul 2024 [monthly]
Recruiting
-
Sep 2022 — Oct 2023 [monthly]
Recruiting
Status: Active Not Recruiting → Recruiting
▶ Show 3 earlier versions
-
Jan 2021 — Sep 2022 [monthly]
Active Not Recruiting
-
Dec 2020 — Jan 2021 [monthly]
Active Not Recruiting
-
Apr 2020 — Dec 2020 [monthly]
Active Not Recruiting
First recorded
Jan 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Groupe Hospitalier Pitie-Salpetriere
For direct contact, visit the study record on ClinicalTrials.gov .